Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Main Study	STARTED	MGL-3196	84
Main Study	STARTED	Placebo	41
Main Study	Received at Least 1 Dose of Study Drug	MGL-3196	84
Main Study	Received at Least 1 Dose of Study Drug	Placebo	41
Main Study	COMPLETED	MGL-3196	74
Main Study	COMPLETED	Placebo	34
Main Study	NOT COMPLETED	MGL-3196	10
Main Study	NOT COMPLETED	Placebo	7
Extension Study	STARTED	MGL-3196	17
Extension Study	STARTED	Placebo	14
Extension Study	COMPLETED	MGL-3196	16
Extension Study	COMPLETED	Placebo	13
Extension Study	NOT COMPLETED	MGL-3196	1
Extension Study	NOT COMPLETED	Placebo	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02912260/flow